LifeSight is operating during Covid-19. If you are a member please visit your LifeSight Account in the usual way for more information. For employer enquiries please contact us in the usual way.
LifeSight is Willis Towers Watson’s master trust, a defined contribution multi-employer pension trust for employers who would benefit from high-quality, low-risk, market-competitive pension provision without the governance burden.
Running a defined contribution pension scheme is becoming complex and costly for a lot of employers. Governance is growing ever more onerous and schemes now have the new pension flexibilities to contend with. Companies have struggled to find a high-quality alternative that has their employees’ needs at heart. LifeSight offers the best attributes of a trust in an outsourced arrangement. Our unique solution looks after the day-to-day running of the scheme, whilst an independent trustee board looks after the interests of your members.
LifeSight gives you access to our leading-edge technology platform, including the award-winning ageOmeter tool, and administration services. Combined with our proven expertise in investments and communications, LifeSight is the complete package.
About Willis Towers Watson
Willis Towers Watson is a leading global advisory, broking and solutions company. Our 40,000-strong team of employees across the world helps organisations of every size and shape to turn risk into a path for growth. With a legacy stretching back to 1828, we’re established and expert advisers on benefit solutions. Our highly-experienced teams already deliver defined contribution (DC) pension services to some of the largest schemes in the country.
We’re currently responsible for the administration of more than £20 billion in DC pension assets – providing investment advice across a DC portfolio of the same amount and delivering engaging communications to over one million DC members. LifeSight is our latest offering to the UK market, and forms part of our growing family of master trusts already operating in Belgium, Germany, the Netherlands and South Africa.